Related Experiment Video
Updated: Jul 13, 2026

Treatment with Locking Intramedullary Nailing for Intertrochanteric Fracture of the Femur Utilizing a New Awl with a Distal Positioner
Published on: June 6, 2025
Minimally invasive plating of high-energy metaphyseal distal tibia fractures
Cory Collinge1, Mark Kuper, Kirk Larson
1Harris Methodist Fort Worth Hospital Orthopedic Trauma Staff, John Peter Smith Orthopedic Surgery Residency, Fort Worth, TX 76104, and Orthopedic Surgery, Texas Tech University, Lubbock, USA. ccollinge@msn.com
Objective:
The purpose of this study is to evaluate clinical results and outcomes of a strict cohort of high-energy injuries of the metaphyseal distal tibia with minimal or no intraarticular involvement treated using the minimally invasive plating concept.
Setting:
Level II trauma center.
Design:
Retrospective analysis of a consecutive case series with limb-specific and whole-person outcomes measures.
Intervention:
Minimally invasive medial plating for high-energy metaphyseal fractures of the distal tibia with little or no intraarticular involvement.
Main Outcome Measurement:
Clinical and radiographic results were assessed at a minimum of 1 year, and outcomes measures were applied at final follow-up at a minimum of 2 years. Limbs were assessed with the American Orthopaedic Foot and Ankle Surgeons (AOFAS) ankle-hindfoot instrument and the method of Olerud and Molander. Patient outcomes were evaluated with the Short Form-36 (SF-36) and the Musculoskeletal Functional Assessment (MFA).
Results:
Twenty-six patients were followed until healed at an average of 36 months (12-56 months). Mean fracture healing time was 35 weeks (12-112 weeks) with acceptable alignment restored (angulation
Conclusions:
Minimally invasive medial plating will restore limb alignment and yield successful clinical outcomes for high-energy metaphyseal fractures of the distal tibia. Despite the significant reoperation rate and prolonged time to union, most patients can expect a predictable return of function. Strong consideration should be given to adjunctive measures in at-risk patients, including those with highly comminuted fracture patterns, bone loss, or Type II or III open fractures.
